» Articles » PMID: 15733244

The Role of the Therapeutic Alliance in the Treatment of Substance Misuse: a Critical Review of the Literature

Overview
Journal Addiction
Specialty Psychiatry
Date 2005 Mar 1
PMID 15733244
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In the past two decades, a number of studies investigating the role of the therapeutic alliance in drug treatment have been published and it is timely that their findings are brought together in a comprehensive review.

Aims: This paper has two principal aims: (1) to assess the degree to which the relationship between drug user and counsellor predicts treatment outcome and (2) to examine critically the evidence on determinants of the quality of the alliance.

Methods: Peer-reviewed research located through the literature databases Medline, PsycInfo and Ovid Full Text Mental Health Journals using predefined search-terms and published in the past 20 years is considered. Further papers were identified from the bibliographies of relevant publications.

Findings: A key finding is that the early therapeutic alliance appears to be a consistent predictor of engagement and retention in drug treatment. With regard to other treatment outcomes, the early alliance appears to influence early improvements during treatment, but it is an inconsistent predictor of post-treatment outcomes. There is relatively little research on the determinants of the alliance. In studies that are available, clients' demographic or diagnostic pre-treatment characteristics did not appear to predict the therapeutic alliance, whereas modest but consistent relationships were reported for motivation, treatment readiness and positive previous treatment experiences.

Conclusions: The therapeutic alliance plays an important role in predicting drug treatment process outcomes, but too little is known about what determines the quality of the relationship between drug users and counsellors.

Citing Articles

Gatekeeping gender-affirming care is detrimental to detrans people.

Ashley F, Parsa N, Kus T, Leveille L, Schevers K, Rider G Int J Transgend Health. 2025; 26(1):235-252.

PMID: 39981285 PMC: 11837931. DOI: 10.1080/15532739.2025.2462582.


A qualitative exploration of triggers for alcohol use and access to support during the COVID-19 pandemic among people identifying as problem drinkers in the United Kingdom.

Yaqubi H, May T, Burton A Drug Alcohol Rev. 2025; 44(3):858-870.

PMID: 39935079 PMC: 11886483. DOI: 10.1111/dar.14013.


Gender Differences in the Effects of Trust on Substance Abuse Severity Among Incarcerated Stimulant Offenders in Japan.

Omiya S, Shimane T, Takagishi Y, Kondo A, Kobayashi M, Takahashi M Neuropsychopharmacol Rep. 2025; 45(1):e12517.

PMID: 39779998 PMC: 11711050. DOI: 10.1002/npr2.12517.


Inpatient detoxification for alcohol and other drug use: qualitative study of patients' accounts of their relationships with staff.

Neale J, Cairns B, Gardiner K, Livingston W, McCarthy T, Perkins A Addict Sci Clin Pract. 2024; 19(1):89.

PMID: 39617936 PMC: 11610126. DOI: 10.1186/s13722-024-00523-0.


Efficacy of a conversational chatbot for cigarette smoking cessation: Protocol of the QuitBot full-scale randomized controlled trial.

Bricker J, Sullivan B, Mull K, Lavista-Ferres J, Santiago-Torres M Contemp Clin Trials. 2024; 147:107727.

PMID: 39490766 PMC: 11620904. DOI: 10.1016/j.cct.2024.107727.